Òscar Miró1,2, Víctor Gil3,4, Carolina Xipell5,6, Carolina Sánchez5,6, Sira Aguiló5,6, Francisco J Martín-Sánchez7, Pablo Herrero8, Javier Jacob9, Alexandre Mebazaa10, Veli-Pekka Harjola11, Pere Llorens12. 1. Emergency Department, Hospital Clínic, Villarroel 170, 08036, Barcelona, Catalonia, Spain. omiro@clinic.cat. 2. "Emergencies: Processes and Pathologies" Research Group, IDIBAPS, Villarroel 170, 08036, Barcelona, Catalonia, Spain. omiro@clinic.cat. 3. Emergency Department, Hospital Clínic, Villarroel 170, 08036, Barcelona, Catalonia, Spain. vgil@clinic.cat. 4. "Emergencies: Processes and Pathologies" Research Group, IDIBAPS, Villarroel 170, 08036, Barcelona, Catalonia, Spain. vgil@clinic.cat. 5. Emergency Department, Hospital Clínic, Villarroel 170, 08036, Barcelona, Catalonia, Spain. 6. "Emergencies: Processes and Pathologies" Research Group, IDIBAPS, Villarroel 170, 08036, Barcelona, Catalonia, Spain. 7. Emergency Department, Hospital Clínico San Carlos, Madrid, Universidad Complutense de Madrid, Madrid, Spain. 8. Emergency Department, Hospital Universitario Central de Asturias, Oviedo, Spain. 9. Emergency Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain. 10. Department of Anesthesiology and Critical Care Medicine, Hospital Lariboisière, U942 Inserm, Université Paris Diderot, Paris, France. 11. Emergency Medicine, Department of Emergency Medicine and Services, Helsinki University, Helsinki University Hospital, Helsinki, Finland. 12. Emergency Department, Home Hospitalization and Short Stay Unit, Hospital General de Alicante, Alicante, Spain.
Abstract
OBJECTIVE: To define the short- and mid-term outcomes of patients discharged after an episode of acute-decompensated heart failure (ADHF) and evaluate the differences between patients discharged directly from the emergency department (ED) and those discharged after hospitalization. METHODS: We performed a prospective, multicenter, cohort-designed study, including consecutive patients diagnosed with ADHF in 27 Spanish EDs. Thirty-four variables on epidemiology, comorbidity, baseline status, vital signs, signs of congestion, laboratory tests, and treatment were collected in every patient. The primary outcome was a combined endpoint of ED revisit (without hospitalization) or hospitalization due to ADHF, or all-cause death. Secondary outcomes were each of these three events individually. Outcomes were obtained by survival analysis at different timepoints in the entire cohort, and crude and adjusted comparisons were carried out between patients discharged directly from the ED and after hospitalization. RESULTS: Of the 3233 patients diagnosed with ADHF during a 2-month period, we analyzed 2986 patients discharged alive: 787 (26.4%) discharged from the ED and 2199 (73.6%) after hospitalization. The cumulative percentages of events for the whole cohort (at 7/30/180 days) for the combined endpoint were 7.8/24.7/57.8; for ED revisit 2.5/9.4/25.5; for hospitalization 4.6/15.3/40.7; and for death 0.9/4.3/16.8. After adjustment for patient profile and center, significant increases were found in the hazard ratios for ED- compared to hospital-discharged patients in the combined endpoint, ED revisit and hospitalization, being higher at short-term [at 7 days, 2.373 (1.678-3.355), 2.069 (1.188-3.602), and 3.071 (1.915-4.922), respectively] than at mid-term [at 180 days, 1.368 (1.160-1.614), 1.642 (1.265-2.132), and 1.302 (1.044-1.623), respectively]. No significant differences were found in death. CONCLUSIONS: Patients with ADHF discharged from the ED have worse outcomes, especially at short term, than those discharged after hospitalization. The definition and implementation of effective strategies to improve patient selection for direct ED discharge are needed.
OBJECTIVE: To define the short- and mid-term outcomes of patients discharged after an episode of acute-decompensated heart failure (ADHF) and evaluate the differences between patients discharged directly from the emergency department (ED) and those discharged after hospitalization. METHODS: We performed a prospective, multicenter, cohort-designed study, including consecutive patients diagnosed with ADHF in 27 Spanish EDs. Thirty-four variables on epidemiology, comorbidity, baseline status, vital signs, signs of congestion, laboratory tests, and treatment were collected in every patient. The primary outcome was a combined endpoint of ED revisit (without hospitalization) or hospitalization due to ADHF, or all-cause death. Secondary outcomes were each of these three events individually. Outcomes were obtained by survival analysis at different timepoints in the entire cohort, and crude and adjusted comparisons were carried out between patients discharged directly from the ED and after hospitalization. RESULTS: Of the 3233 patients diagnosed with ADHF during a 2-month period, we analyzed 2986 patients discharged alive: 787 (26.4%) discharged from the ED and 2199 (73.6%) after hospitalization. The cumulative percentages of events for the whole cohort (at 7/30/180 days) for the combined endpoint were 7.8/24.7/57.8; for ED revisit 2.5/9.4/25.5; for hospitalization 4.6/15.3/40.7; and for death 0.9/4.3/16.8. After adjustment for patient profile and center, significant increases were found in the hazard ratios for ED- compared to hospital-discharged patients in the combined endpoint, ED revisit and hospitalization, being higher at short-term [at 7 days, 2.373 (1.678-3.355), 2.069 (1.188-3.602), and 3.071 (1.915-4.922), respectively] than at mid-term [at 180 days, 1.368 (1.160-1.614), 1.642 (1.265-2.132), and 1.302 (1.044-1.623), respectively]. No significant differences were found in death. CONCLUSIONS:Patients with ADHF discharged from the ED have worse outcomes, especially at short term, than those discharged after hospitalization. The definition and implementation of effective strategies to improve patient selection for direct ED discharge are needed.
Authors: Alexandre Mebazaa; M Birhan Yilmaz; Phillip Levy; Piotr Ponikowski; W Frank Peacock; Said Laribi; Arsen D Ristic; Ekaterini Lambrinou; Josep Masip; Jillian P Riley; Theresa McDonagh; Christian Mueller; Christopher deFilippi; Veli-Pekka Harjola; Holger Thiele; Massimo F Piepoli; Marco Metra; Aldo Maggioni; John J V McMurray; Kenneth Dickstein; Kevin Damman; Petar M Seferovic; Frank Ruschitzka; Adelino F Leite-Moreira; Abdelouahab Bellou; Stefan D Anker; Gerasimos Filippatos Journal: Eur Heart J Date: 2015-05-21 Impact factor: 29.983
Authors: Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer Journal: Eur J Heart Fail Date: 2016-05-20 Impact factor: 15.534
Authors: Oscar Miró; Pere Llorens; Francisco Javier Martín-Sánchez; Pablo Herrero; Javier Jacob; María José Pérez-Durá; Cesar González; Héctor Alonso; Victor Gil; Ana Bella Alvarez; Rafel Perelló; Juan Jorge González-Armengol Journal: Eur J Emerg Med Date: 2010-08 Impact factor: 2.799
Authors: Sean Collins; Alan B Storrow; Nancy M Albert; Javed Butler; Justin Ezekowitz; G Michael Felker; Gregory J Fermann; Gregg C Fonarow; Michael M Givertz; Brian Hiestand; Judd E Hollander; David E Lanfear; Phillip D Levy; Peter S Pang; W Frank Peacock; Douglas B Sawyer; John R Teerlink; Daniel J Lenihan Journal: J Card Fail Date: 2014-07-18 Impact factor: 5.712
Authors: Sean P Collins; Daniel P Schauer; Amit Gupta; Hermine Brunner; Alan B Storrow; Mark H Eckman Journal: Am J Emerg Med Date: 2009-03 Impact factor: 2.469
Authors: Ò Miró; R Escoda; F J Martín-Sánchez; P Herrero; J Jacob; M Rizzi; A Aguirre; J A Andueza; H Bueno; P Llorens Journal: Rev Clin Esp (Barc) Date: 2016-03-19
Authors: Lisa Calder; Sarah Tierney; Yue Jiang; Austin Gagné; Andrew Gee; Elisabeth Hobden; Christian Vaillancourt; Jeffrey Perry; Ian Stiell; Alan Forster Journal: Am J Emerg Med Date: 2013-10-17 Impact factor: 2.469
Authors: Douglas S Lee; Michael J Schull; David A Alter; Peter C Austin; Andreas Laupacis; Alice Chong; Jack V Tu; Thérèse A Stukel Journal: Circ Heart Fail Date: 2010-01-27 Impact factor: 8.790
Authors: Òscar Miró; Koji Takagi; Étienne Gayat; Víctor Gil; Pere Llorens; Francisco J Martín-Sánchez; Javier Jacob; Pablo Herrero-Puente; Rosa Escoda; María Pilar López-Díez; Amparo Valero; Marta Fuentes; José M Garrido; Eva Salvo; Miguel A Rizzi; Alfons Aguirre; Lissete Travería Bécquer; Alberto Domínguez-Rodríguez; Joan Padrosa; Gemma Martínez; Mattia Arrigo; Yonathan Freund; Alexandre Mebazaa Journal: Clin Res Cardiol Date: 2019-04-29 Impact factor: 5.460
Authors: Austin S Kilaru; Nicholas Illenberger; Zachary F Meisel; Peter W Groeneveld; Manqing Liu; Angira Mondal; Nandita Mitra; Raina M Merchant Journal: Circ Cardiovasc Qual Outcomes Date: 2022-09-08
Authors: Pere Llorens; Patricia Javaloyes; Francisco Javier Martín-Sánchez; Javier Jacob; Pablo Herrero-Puente; Víctor Gil; José Manuel Garrido; Eva Salvo; Marta Fuentes; Héctor Alonso; Fernando Richard; Francisco Javier Lucas; Héctor Bueno; John Parissis; Christian E Müller; Òscar Miró Journal: Clin Res Cardiol Date: 2018-05-04 Impact factor: 5.460
Authors: Òscar Miró; Xavier Rossello; Elke Platz; Josep Masip; Danielle M Gualandro; W Frank Peacock; Susanna Price; Louise Cullen; Salvatore DiSomma; Mucio Tavares de Oliveira; John Jv McMurray; Francisco J Martín-Sánchez; Alan S Maisel; Christiaan Vrints; Martin R Cowie; Héctor Bueno; Alexandre Mebazaa; Christian Mueller Journal: Eur Heart J Acute Cardiovasc Care Date: 2020-08
Authors: Ahmad Shoaib; M Farag; J Nolan; A Rigby; A Patwala; M Rashid; C S Kwok; R Perveen; A L Clark; M Komajda; J G F Cleland Journal: Clin Res Cardiol Date: 2018-10-25 Impact factor: 5.460